Cross-sectional association with pre-radiographic anatomical change Schiphof et al. (2014) Adj OR Cross-sectional association with pre-radiographic anatomical change Cibere et al. (2010) Longitudinal associations with incident ROA † adjusted OR: Cooper et al. (2000) ; De Klerk et al. (2012) . ‡ crude OR: Hart et al. (1999) ; Nishimura et al. (2011); Muraki et al. (2012) ; unpublished data from Runhaar et al. (2015) Peat et al. (2010) Individual risk prediction OR pain most days last month 1.6 (1.2 to 2.2) +2% variance explained Kerkhof et al. (2014) "Markers proposed for classifying or predicting risk in individual subjects must be held to a much higher standard than merely being associated with outcome.
Their sensitivities and specificities must be shown to be adequate through appropriate statistical evaluations." Pepe et al. (2004) , p889
• Conventional clinical signs and symptoms (modestly) associated with MRI abnormalities and with future incident ROA are found in a minority of the population in preradiographic stages • Individual risk prediction requires multiple variables. Thusfar conventional clinical signs and symptoms make small marginal contributions to prediction of individual risk of iROA. • Traditional risk factors, exposure histories, and clinical variables remain important for stratification for preventive medicine. However, the majority of future cases of 'clinically significant OA' are likely to arise from the much more numerous subpopulation of persons in the low-medium strata • Illness and disease states generally track themselves over time far more strongly than they predict each other
Interpretation
Redefining early symptom states • Subthreshold symptoms: 'an awareness' of the knee, loss of confidence, needing to 'be careful' • Intermittent symptoms, predictability of these • Early emergence of adaptive behaviours selection (e.g. performing some activities less often) -optimisation (e.g. greater advance planning of activities, including anticipatory analgesic use) -compensatory (e.g. modifying the way activities are performed) Qualitative research Roos et al. (1998) ; Gooberman-Hill et al. (2007) ; Hawker et al. (2008a) ; Maly & Cott (2009) ; Morden et al. (2009) ; Clarke et al. (2014) ; Gignac et al. (2002) Measurement instruments: KOOS, ICOAP, QUiKS 1) I have no knee pain 2) My pain is predictable (I know what brings it on) and usually sharp. It is usually brought on by a trigger (like an activity or movement) that has kept me from high impact activities, such as skiing, but has not had much other impact on my physical activities
3) My predictable pain comes more and more with unpredictable (comes when I don't expect it) locking of knees or other knee joint symptoms.
The pain is becoming more constant and is affecting daily activities, such as walking and climbing stairs 4) My pain is constant, and is dull and aching. And, on top of this pain, I have short episodes of often unpredictable intense pain that leaves me feeling exhausted. Because of this pattern of pain, I am avoiding a lot of social and recreational activities • A new wave of promising measurements and health state definitions. Given adequate psychometric properties (and conditional on licenses) they ought to be embedded in studies at every opportunity to build up the evidence base. • A priority study is to use these measures along with known risk factors and exposure histories to describe the (prognostically-relevant) clinical and disease profile of patients at the point when their problem is presented to recognised by (primary) healthcare services • The point of entry into UK primary care is fuzzy and in many cases precedes formal diagnosis by several years. • Patterns of pre-diagnosis consultations and risk factors within the EHR may form another practical method of defining early OA states

Concluding remarks
• Selective; relative merits of preventive medicine vs other approaches to prevention? Evidence on the relative costs, effectiveness, harms of early vs late intervention; differences for different OA phenotypes? • Disease, illness, presentation to healthcare: …sensible location of these in time • Clinical manifestations evident in pre-radiographic phases and evidence of growth in the transition into ROA but often little/no signal from existing patient-reported measures • Some promising measurements; greater application • Conventional risk factors remain important for stratification
• Distinction between levels of prevention more apparent than real • Multiple transitions in episodic phasic development and progression?
• Keep risk stratification simple; integrate within EHR?
• Orientate to population-relevant outcomes, e.g. YLD, time spent in persistent pain, lost productivity and person-focussed (as opposed to disease-focussed) strategies • Attempt to close rather than widen health inequities • Involve patients and public
